A good little write up in the afr today (page 25), saying brokers believe insto's will take more interest in acl. It also states that gsk is Alchemia's partner (which is incorrect, of course).
I can't post, as I don't have on-line access.
I sure looks like the new ceo is going to keep the market more informed, which is a good thing.
The drums should start to roll as we near phase 2 results at the end of May.
fantastic cancer results, page-15
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable